Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4269/ajtmh.21-0603 http://scihub22266oqcxt.onion/10.4269/ajtmh.21-0603 34715676!8641332!34715676     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\34715676.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Am+J+Trop+Med+Hyg 2021 ; 105 (6): 1519-1520 Nephropedia Template TP {{tp|p=34715676|t=2021. Antibiotic Overuse for COVID-19: Are We Adding Insult to Injury?|pdf=|usr=}}{{34715676}} gab.com Text Antibiotic Overuse for COVID-19: Are We Adding Insult to Injury JO: Am J Trop Med Hyg http://www.kidney.de/pget.php?&tw=1&pmid=34715676 #FOAvip In this study, we described the proportion of COVID-19 patients started on antibiotics empirically and the work-ups performed to diagnose bacterial superinfection. We used a retrospective cohort study design involving medical records of symptomatic, hospitalized COVID-19 patients who were admitted to these centers. A total of 481 patients were included, with a median age of 41.0 years (interquartile range, 28-58.5 years). A total of 72.1% (N = 347) of COVID-19 patients received antibiotics, either before or during admission. This is troublesome because none of the patients' bacterial culture or inflammatory markers, such as the erythrocyte sedimentation rate or C-reactive protein, were evaluated, and only 73 (15.2%) underwent radiological investigations. Therefore, national COVID-19 guidelines should emphasize the rational use of antibiotics for the treatment of COVID-19, a primarily viral disease. Integrating antimicrobial stewardship into the COVID-19 response and expanding microbiological capacities in low-income countries are indispensable. Otherwise, we risk one pandemic aggravating another. Twit Text FOAVip Antibiotic Overuse for COVID-19: Are We Adding Insult to Injury ????Am J Trop Med Hyg http://www.kidney.de/pget.php?&tw=1&pmid=34715676 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34715676 #FOAvip English Wikipedia <ref>{{Cite pmid|34715676}}</ref> Antibiotic Overuse for COVID-19: Are We Adding Insult to Injury? #MMPMID34715676 Abdela SG; Liesenborghs L; Tadese F; Abegaz SH; Bayuh FB; Asmamaw EA; Mebrate TA; Mamo AE; Embiale W; Hunegnaw S; Hundie DB; Hurissa Z; Agero G; Kaso AW; Mebrate MA; van Henten S; van Griensven J Am J Trop Med Hyg 2021[Oct]; 105 (6): 1519-1520 PMID34715676show ga In this study, we described the proportion of COVID-19 patients started on antibiotics empirically and the work-ups performed to diagnose bacterial superinfection. We used a retrospective cohort study design involving medical records of symptomatic, hospitalized COVID-19 patients who were admitted to these centers. A total of 481 patients were included, with a median age of 41.0 years (interquartile range, 28-58.5 years). A total of 72.1% (N = 347) of COVID-19 patients received antibiotics, either before or during admission. This is troublesome because none of the patients' bacterial culture or inflammatory markers, such as the erythrocyte sedimentation rate or C-reactive protein, were evaluated, and only 73 (15.2%) underwent radiological investigations. Therefore, national COVID-19 guidelines should emphasize the rational use of antibiotics for the treatment of COVID-19, a primarily viral disease. Integrating antimicrobial stewardship into the COVID-19 response and expanding microbiological capacities in low-income countries are indispensable. Otherwise, we risk one pandemic aggravating another. |*COVID-19 Drug Treatment[MESH] |*SARS-CoV-2[MESH] |Adult[MESH] |Anti-Bacterial Agents/*administration & dosage[MESH] |Antimicrobial Stewardship[MESH] |Bacterial Infections/diagnosis/drug therapy/epidemiology[MESH] |Cohort Studies[MESH] |Ethiopia/epidemiology[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Practice Guidelines as Topic[MESH] |Retrospective Studies[MESH]Antibiotic Overuse for COVID-19: Are We Adding Insult to Injury?(epmc).pdf DeepDyve Pubget Overpricing